Literature DB >> 849377

The effect of cholestyramine on the faecal excretion of bile acids and neutral steroids in familial hypercholesterolaemia.

C D Moutafis, L A Simons, N B Myant, P W Adams, V Wynn.   

Abstract

The faecal excretion of total bile acids was measured in two normal subjects and in seven patients with familial hypercholesterolaemia (four heterozygotes and three homozygotes) in the untreated state and during treatment with near-maximal doses of cholestyramine. There were no significant differences between the three groups. The increase in bile-acid excretion in response to cholestyramine was as great in the homozygotes as in the normal subjects. It is concluded that familial hypercholesterolaemia is not generally due to an inherited defect in the mechanisms for catabolizing cholesterol to bile acids.

Entities:  

Mesh:

Substances:

Year:  1977        PMID: 849377     DOI: 10.1016/0021-9150(77)90085-5

Source DB:  PubMed          Journal:  Atherosclerosis        ISSN: 0021-9150            Impact factor:   5.162


  3 in total

1.  Combination treatment with cholestyramine and bezafibrate for heterozygous familial hypercholesterolaemia.

Authors:  L D Curtis; A C Dickson; K L Ling; J Betteridge
Journal:  BMJ       Date:  1988-07-16

2.  Metabolic studies in familial hypercholesterolemia. Evidence for a gene-dosage effect in vivo.

Authors:  D W Bilheimer; N J Stone; S M Grundy
Journal:  J Clin Invest       Date:  1979-08       Impact factor: 14.808

Review 3.  Receptor-mediated low-density lipoprotein catabolism.

Authors:  F A Spengel; G R Thompson
Journal:  Klin Wochenschr       Date:  1982-04-01
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.